作者：
Jing,Ni [1]
;
Sheheryar,Kabraji [2]
;
Shaozhen,Xie [1]
;
Yanzhi,Wang [3]
;
Peichen,Pan [4]
;
Xiaofang,He [1]
;
Zongming,Liu [2]
;
Jose Palbo,Leone [1]
;
Henry W,Long [1]
;
Myles A,Brown [2]
;
Eric P,Winer [5]
;
Deborah A R,Dillon [1]
;
Nancy U,Lin [6]
;
Jean J,Zhao [1]
作者单位：
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
[1]
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02115, USA.
[2]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
[3]
Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, 02115, USA.
[4]
College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, P. R. China.
[5]
Department of Radiation Oncology, the first affiliated hospital of Sun Yat-Sen University, Guangzhou, 510080, P. R. China.
[6]
Key Laboratory of Bionic Engineering (Ministry of Education), College of Biological and Agricultural Engineering, Jilin University, Changchun, Jilin, 130022, P. R. China.
[7]
Department of Anesthesiology, Jilin Cancer Hospital, Changchun, Jilin, 130000, P. R. China.
[8]
Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
[9]
Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA.
[10]
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. jean_zhao@dfci.harvard.edu.
[11]
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02115, USA. jean_zhao@dfci.harvard.edu.
[12]
Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, 02115, USA. jean_zhao@dfci.harvard.edu.
[13]
DOI
10.1038/s41467-022-29081-2
PMID
35304445
发布时间
2023-03-17
换一批
换一批
